Literature DB >> 20483171

Nocturnal sleep architecture disturbances in early methadone treatment patients.

Le Xiao1, Yi-lang Tang, Alicia K Smith, Yu-tao Xiang, Li-xia Sheng, Yong Chi, Wan-jun Du, Song Guo, Zuo-ning Jiang, Guo-fu Zhang, Xiao-nian Luo.   

Abstract

The subjective and objective sleep patterns of patients with opioid dependence have been previously reported, but the sleep characteristics of patients in early methadone treatment, especially the objective sleep patterns, remain largely unexamined. This study was designed to explore the nocturnal sleep structure of patients on early methadone treatment. Twenty male methadone treatment (MT) patients and 20 male age- and body mass index-matched controls were assessed with overnight limited polysomnography. Subjective sleep was assessed using the Pittsburgh Sleep Quality Index (PSQI) and the Epworth Sleepiness Scale (ESS). Compared with healthy controls, MT patients had lower sleep efficiency, shorter total sleep time, more awakenings and shorter slow wave sleep (SWS). The PSQI and ESS scores in MT patients were significantly higher than in the controls. ESS scores of the patients were significantly associated with the SWS. The findings indicate that patients in early MT have poor sleep quality and abnormal sleep architecture.
Copyright © 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20483171     DOI: 10.1016/j.psychres.2009.02.003

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  16 in total

1.  Correlates of sleep quality and excessive daytime sleepiness in people with opioid use disorder receiving methadone treatment.

Authors:  Stephen R Baldassarri; Mark Beitel; Andrey Zinchuk; Nancy S Redeker; David E Oberleitner; Lindsay M S Oberleitner; Danilo Carrasco; Lynn M Madden; Nathan Lipkind; David A Fiellin; Lori A Bastian; Kevin Chen; H Klar Yaggi; Declan T Barry
Journal:  Sleep Breath       Date:  2020-06-17       Impact factor: 2.816

2.  Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients.

Authors:  Kelly E Dunn; Patrick H Finan; D Andrew Tompkins; Eric C Strain
Journal:  Addict Behav       Date:  2017-07-14       Impact factor: 3.913

3.  A prospective, longitudinal study of sleep disturbance and comorbidity in opiate dependence (the ANRS Methaville study).

Authors:  Sandra Nordmann; Caroline Lions; Antoine Vilotitch; Laurent Michel; Marion Mora; Bruno Spire; Gwenaelle Maradan; Alain Morel; Perrine Roux; M Patrizia Carrieri
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

4.  Neuropharmacology of Sleep and Wakefulness: 2012 Update.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2012-09-04

5.  Chronic Opioid Therapy and Sleep: An American Academy of Sleep Medicine Position Statement.

Authors:  Ilene M Rosen; R Nisha Aurora; Douglas B Kirsch; Kelly A Carden; Raman K Malhotra; Kannan Ramar; Fariha Abbasi-Feinberg; David A Kristo; Jennifer L Martin; Eric J Olson; Carol L Rosen; James A Rowley; Anita V Shelgikar
Journal:  J Clin Sleep Med       Date:  2019-11-15       Impact factor: 4.062

6.  Sleep reductions associated with illicit opioid use and clinic-hour changes during opioid agonist treatment for opioid dependence: Measurement by electronic diary and actigraphy.

Authors:  Jeremiah W Bertz; David H Epstein; David Reamer; William J Kowalczyk; Karran A Phillips; Ashley P Kennedy; Michelle L Jobes; Greg Ward; Barbara A Plitnick; Mariana G Figueiro; Mark S Rea; Kenzie L Preston
Journal:  J Subst Abuse Treat       Date:  2019-08-14

7.  Associations between insufficient sleep and prescription opioid misuse among high school students in the United States.

Authors:  Cornelius B Groenewald; Jennifer A Rabbitts; See Wan Tham; Emily F Law; Tonya M Palermo
Journal:  J Clin Sleep Med       Date:  2021-11-01       Impact factor: 4.062

8.  Worsening sleep quality across the lifespan and persistent sleep disturbances in persons with opioid use disorder.

Authors:  Jennifer D Ellis; Jami L Mayo; Charlene E Gamaldo; Patrick H Finan; Andrew S Huhn
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

9.  Recommended protocols for the Multiple Sleep Latency Test and Maintenance of Wakefulness Test in adults: guidance from the American Academy of Sleep Medicine.

Authors:  Lois E Krahn; Donna L Arand; Alon Y Avidan; David G Davila; William A DeBassio; Chad M Ruoff; Christopher G Harrod
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.324

10.  Sleep disturbance as a therapeutic target to improve opioid use disorder treatment.

Authors:  Andrew S Huhn; Patrick H Finan
Journal:  Exp Clin Psychopharmacol       Date:  2021-06-10       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.